GOLDMAN SACHS GROUP INC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 81 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$707,000
+381.0%
535,304
+568.8%
0.00%
Q1 2018$147,000
+81.5%
80,036
+108.4%
0.00%
Q4 2017$81,000
+224.0%
38,399
+241.8%
0.00%
Q3 2017$25,000
-74.7%
11,233
-80.4%
0.00%
Q2 2017$99,0000.0%57,432
+43.0%
0.00%
Q1 2017$99,000
-36.1%
40,176
-33.5%
0.00%
Q3 2016$155,000
+198.1%
60,455
+77.7%
0.00%
Q2 2016$52,000
-31.6%
34,030
-11.7%
0.00%
Q1 2016$76,000
-14.6%
38,521
+33.7%
0.00%
Q4 2015$89,000
-92.4%
28,801
-91.8%
0.00%
Q3 2015$1,177,000
+89.5%
351,297
+110.0%
0.00%
Q2 2015$621,000
+71.5%
167,293
+71.4%
0.00%
Q1 2015$362,000
+1473.9%
97,582
+872.1%
0.00%
Q3 2014$23,000
-97.9%
10,038
-97.3%
0.00%
Q2 2014$1,082,000
-55.5%
373,365
-37.4%
0.00%
-100.0%
Q1 2014$2,434,000
+6305.3%
596,763
+2603.7%
0.00%
Q1 2012$38,00022,0720.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,030,604$4,285,0000.70%
Virtus ETF Advisers LLC 180,348$381,0000.48%
Bain Capital Public Equity Management, LLC 4,564,744$9,632,0000.35%
Baker Brothers Advisors 18,315,802$38,646,0000.34%
Stanley-Laman Group, Ltd. 483,773$1,021,0000.22%
FIRST MIDWEST BANK TRUST DIVISION 493,689$1,042,0000.13%
GMT CAPITAL CORP 3,875,546$8,178,0000.08%
Vident Investment Advisory, LLC 640,270$1,351,0000.06%
SABBY MANAGEMENT, LLC 307,987$650,0000.06%
Palo Alto Investors LP 616,355$1,301,0000.06%
View complete list of IDERA PHARMACEUTICALS INC shareholders